Cantourage Group SE: Strong growth continues - another monthly sales record
in June 2024

EQS-News: Cantourage Group SE / Key word(s): Monthly Figures
Cantourage Group SE: Strong growth continues - another monthly sales record
in June 2024

03.07.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Not for release, publication or distribution, directly or indirectly, in or
into the United States of America, Australia, Canada or Japan or any other
jurisdiction in which such release, publication or distribution would be
unlawful. The important notes at the end of this announcement need to be
observed.

Cantourage Group SE: Strong growth continues - another monthly sales record
in June 2024

  * High growth dynamics since the partial legalization of cannabis in
    Germany came into force continue and gain further momentum

* Monthly sales increased to EUR 4.1 million in June 2024

  * Cantourage and Telecan establish themselves as a main point of contact
    for patients

Berlin, July 03, 2024 - Cantourage Group SE (hereinafter referred to as
"Cantourage," ISIN: DE000A3DSV01, www.cantourage.com), a leading European
company for the production and distribution of cannabis, once again achieved
record monthly sales in June 2024. Sales revenue of EUR 4.1 million was
generated in the period. Cantourage had already set a new record for sales
in the previous month (sales in May 2024: EUR 3.5 million) as a result of
the noticeable increase in demand for high-quality cannabis products.

Since the partial legalization of cannabis in Germany came into effect in
April 2024, the demand for cannabis products in pharmacies has increased
significantly. At the same time, Cantourage is also continuously expanding
its collaboration with doctors as part of its online platform for cannabis
on prescription, Telecan ( www.telecan.eu). This provides more and more
patients with a simple and direct route to cannabis therapy. Overall,
Cantourage's business has grown dynamically in all core areas most recently.

"Thanks to our flexible business model, we have prepared for the ongoing
liberalization of cannabis in Germany and other European countries at an
early stage in recent years. In doing so, we were able to bring on board
many well-known cannabis growers from all over the world as partners and
also expand our own production capacities in time for the expected increase
in demand. We have benefited greatly from this, particularly since April
2024. We now expect the positive growth momentum from the second quarter to
continue in the second half of 2024," said Philip Schetter, CEO of
Cantourage.

About Cantourage

Cantourage is a leading European producer and distributor of cannabis
flowers and cannabis-based medicinal preparations and drugs. The
Berlin-based company was founded in 2019 by industry pioneers Norman
Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. With an experienced
management team and its "Fast Track Access" platform, Cantourage enables
producers from around the world to become part of the growing European
medical cannabis market faster, easier and more cost-effectively by
processing and distributing their cannabis raw materials and extracts. In
this context, Cantourage ensures compliance with the highest European
pharmaceutical quality standards at all times. The company offers
pharmaceutical-grade products in all relevant market segments: dried flower,
extracts, dronabinol and cannabidiol. Cantourage was listed on the Frankfurt
Stock Exchange on 11 November 2022 and is listed under ticker symbol "HIGH."

Further information: www.cantourage.com

This announcement does not constitute a public offer or an advertisement for
a public offer to sell securities, in particular not within the meaning of
Regulation (EU) 2017/1129 (Prospectus Regulation).

Press contact at Cantourage:

Frederick Steudemann

Phone: +49 (0)30 4701 350 - 50

steudemann@cantourage.com


---------------------------------------------------------------------------

03.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        Cantourage Group SE
                   Feurigstraße 54
                   10827 Berlin
                   Germany
   E-mail:         info@cantourage.com
   Internet:       https://www.cantourage.com/
   ISIN:           DE000A3DSV01
   WKN:            A3DSV0
   Listed:         Regulated Unofficial Market in Berlin, Dusseldorf,
                   Frankfurt (Scale), Munich, Stuttgart, Tradegate
                   Exchange
   EQS News ID:    1938195

End of News EQS News Service
---------------------------------------------------------------------------

1938195 03.07.2024 CET/CEST